Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia

• Päätekijät: Yao Zhang (Tekijä), Jing Sun (Tekijä), Jie Gao (Tekijä), Weiyan Sun (Tekijä), Liang Xu (Tekijä), Chunjuan Zhai (Tekijä), WenYan Su (Tekijä), Haiping Wang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Rituximab (RTX) is a monoclonal antibody commonly used to treat PLA2R-associated membranous nephropathy (MN). This report presents a case of refractory MN in a patient who experienced severe hypokalemia, a rare but clinically significant condition, after the 5th RTX infusion. Clinicians should be aw...